CVA Family Office’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.64K Buy
+23
New +$1.57K ﹤0.01% 1573
2025
Q2
Sell
-11
Closed -$435 1394
2025
Q1
$435 Buy
+11
New +$487 ﹤0.01% 1347

Other funds holding NGVT

CVA Family Office's NGVT Position: Q1 2026 in Review

CVA Family Office opened a new position in Ingevity (NGVT) in Q1 2026: 23 shares worth $1.64K. The stake represents ﹤0.01% of the portfolio and ranks #1573 among its holdings. This is a return to the name: CVA Family Office previously reported a position in NGVT as recently as Q1 2025.

CVA Family Office first reported a position in NGVT in Q1 2025 and has held it in 2 quarters since. 307 funds tracked by Wall St. Rank hold NGVT as of Q1 2026.

  • CVA Family Office held 23 shares of Ingevity worth $1.64K as of Q1 2026.
  • Ingevity was a new CVA Family Office position in Q1 2026.
  • Ingevity made up ﹤0.01% of CVA Family Office's portfolio in Q1 2026, its #1573 holding.
  • CVA Family Office first reported a position in Ingevity in Q1 2025 and has held it in 2 quarters since.
  • 307 funds tracked by Wall St. Rank held Ingevity as of Q1 2026.

Based on CVA Family Office's 13F filing for Q1 2026, filed 29 Apr 2026.